Actively Recruiting

Age: 18Years +
FEMALE
ID06089083

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery - PROOF Prospective Cohort Study

Led by University of California, San Francisco · Updated on 2026-01-26

500

Participants Needed

2

Research Sites

313 weeks

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

C

Conquer Cancer Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying how frailty, a condition that makes people more vulnerable to health stressors, affects outcomes and quality of life in adults newly diagnosed with gynecologic cancer. The study aims to assess risk factors linked to frailty and compare quality of life, surgical, and cancer-related outcomes between patients who are frail and those who are not. This observational study involves participants from gynecologic oncology services at two institutions. Participants will take part in physical function assessments and complete quality of life surveys before their standard surgery for cancer. After surgery, they will be followed for at least three months and up to one year to monitor recovery and quality of life. Additionally, medical records will be reviewed periodically for up to 10 years to assess long-term cancer outcomes, including survival and treatment delays. During the study, participants will undergo regular physical and self-reported evaluations every three months, along with medical record reviews. Researchers will measure frailty at enrollment and track outcomes such as length of hospital stay, readmissions, surgical complications, and chemotherapy timing. Long-term follow-up will assess progression-free and overall survival, as well as treatment delays. The total participation time may extend to 10 years for some assessments.

CONDITIONS

Brief Title

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or greater
  • Undergoing evaluation for a newly diagnosed gynecologic malignancy
  • Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it
Not Eligible

You will not qualify if you...

  • Contraindication to any study-related procedure or assessment
  • Does not speak a language for which the consent form and study materials are available

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) at the time of diagnosis

Diagnostic Evaluation

Duration - Up to 1 month before surgery

Participants undergo physical function assessments and complete questionnaires to assess frailty and quality of life prior to surgery.

Visits every 3 months ± 4 weeks prior to surgery

Surgery and Immediate Post-operative Care

Duration - Surgery day plus immediate post-operative period

Participants undergo standard of care surgery for gynecologic cancer, which is non-interventional within this study.

Medical record review of surgical data

Post-operative Follow-up

Duration - At least 3 months post-surgery

Participants are followed for at least 3 months after surgery with physical assessments and quality of life surveys to monitor recovery.

Follow-up visits every 3 months ± 4 weeks for up to one year after diagnosis

Long-term Monitoring

Duration - Up to 10 years after enrollment

Participants' medical records are reviewed periodically for oncologic outcomes such as progression-free survival, overall survival, and chemotherapy delays.

Periodic medical record reviews

Trial Site Locations

Total: 2 locations

1

University of California, San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

2

Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

J

Janet Titzler

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Study of 3D-printed Custom Applicators for Intracavitary HDR...

Gynecologic Cancer

Actively Recruiting

1 location

A Multi-Modality Comparison of Needle Placement During Gynec...

Gynecologic Cancer

Actively Recruiting

1 location

A Phase I Clinical Study to Assess the Safety and Efficacy o...

Ovarian Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here